Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901

Yasuyuki Takeda, Makoto Tanaka, Hiroyuki Miyazaki, Suguru Takeo, Kikuo Nomoto, Yasunobu Yoshikai

    Research output: Contribution to journalArticle

    16 Citations (Scopus)

    Abstract

    The growth of MethA tumor was significantly inhibited by oral administration of the α-glucan SPR-901 in BALB/c (+/+) mice but not in nude mice. Mice treated orally with SPR-901 exhibited an augmentation of antigen-specific resistance against rechallenge with the tumor cells. The tumor-neutralizing activity of regional lymph node cells from MethA-bearing mice against the tumor was augmented by oral administration of SPR-901. The tumor-neutralizing activity of lymph node cells from SPR-901-treated mice mainly appeared in Lyt2+cells. Furthermore, lymphokine-activated killer activity of these cells was enhanced by administration of SPR-901. The antitumor effect of SPR-901 was abrogated in mice depleted of either L3T4+ or Lyt2+ cells, and in cyclosporin-A-treated mice. These results suggest that Lyt2+ cells are important effector cells in MethA-bearing mice orally adminstered SPR-901 and that functional exertion of both Lyt2+ and L3T4+T cells is necessary for the antitumor effect of orally administered SPR-901 in vivo.

    Original languageEnglish
    Pages (from-to)143-148
    Number of pages6
    JournalCancer Immunology Immunotherapy
    Volume38
    Issue number3
    DOIs
    Publication statusPublished - May 1 1994

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology
    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901'. Together they form a unique fingerprint.

  • Cite this